BRULX
Price
$17.90
Change
+$0.13 (+0.73%)
Updated
Jun 2 closing price
Net Assets
331.29M
RMEBX
Price
$62.83
Change
+$0.38 (+0.61%)
Updated
Jun 2 closing price
Net Assets
114.65B
Interact to see
Advertisement

BRULX vs RMEBX

Header iconBRULX vs RMEBX Comparison
Open Charts BRULX vs RMEBXBanner chart's image
BRULX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
BRULX vs. RMEBX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRULX is a Hold and RMEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 115B vs. BRULX (331M). BRULX (1.08) and RMEBX (1.04) have matching dividends . BRULX was incepted earlier than RMEBX: BRULX (11 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than BRULX (0.69). BRULX is a more actively managed with annual turnover of: 48.00 vs. RMEBX (30.00). BRULX has a lower initial minimum investment than RMEBX: BRULX (0) vs RMEBX (250). BRULX annual gain was more profitable for investors over the last year : 14.56 vs. RMEBX (9.98). RMEBX return over 5 years is better than : 32.93 vs. BRULX (14.89).
BRULXRMEBXBRULX / RMEBX
Total Expense Ratio0.641.0760%
Annual Report Gross Expense Ratio0.691.0764%
Fund Existence11 years12 years-
Gain YTD13.6925.801236%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets331M115B0%
Annual Yield % from dividends1.081.04105%
Returns for 1 year14.569.98146%
Returns for 3 years34.9934.14103%
Returns for 5 years14.8932.9345%
Returns for 10 years91.3889.84102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVCO12.161.49
+13.96%
Silvaco Group Inc
ZG36.580.14
+0.38%
Zillow Group
ORIQU10.30N/A
N/A
Origin Investment Corp I
YHNA10.86N/A
N/A
YHN Acquisition I Ltd
TSHA5.67-0.30
-5.03%
Taysha Gene Therapies